P-266 Aflibercept as a second line chemotherapy in metastatic colorectal cancer. One centre experience

Authors :: E. González-Flores
C. Sanchez-Toro
J. García-García
A. Villaescusa
V. Conde
M.T. Delgado Urena
Beatriz González-Astorga
Source :: Annals of Oncology. 26:iv78
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Colorectal cancer
Hematology
medicine.disease
Chemotherapy regimen
Second line chemotherapy
Internal medicine
medicine
business
Aflibercept
medicine.drug

Full Text Access

Tools